| In vivo gene delivery by nonviral vectors: overcoming hurdles? Y Zhang, A Satterlee, L Huang Molecular therapy 20 (7), 1298-1304, 2012 | 461 | 2012 |
| Delivery of oligonucleotides with lipid nanoparticles Y Wang, L Miao, A Satterlee, L Huang Advanced drug delivery reviews 87, 68-80, 2015 | 201 | 2015 |
| Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment M Huo, Y Zhao, AB Satterlee, Y Wang, Y Xu, L Huang Journal of Controlled Release 245, 81-94, 2017 | 151 | 2017 |
| Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model J Zhang, L Miao, S Guo, Y Zhang, L Zhang, A Satterlee, WY Kim, L Huang Journal of controlled release 182, 90-96, 2014 | 118 | 2014 |
| Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic KM Au, A Satterlee, Y Min, X Tian, YS Kim, JM Caster, L Zhang, T Zhang, ... Biomaterials 82, 178-193, 2016 | 108 | 2016 |
| Current and future theranostic applications of the lipid-calcium-phosphate nanoparticle platform AB Satterlee, L Huang Theranostics 6 (7), 918, 2016 | 61 | 2016 |
| Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy Y Li, Y Wu, L Huang, L Miao, J Zhou, AB Satterlee, J Yao Journal of Controlled Release 228, 107-119, 2016 | 58 | 2016 |
| Enhancing nanoparticle accumulation and retention in desmoplastic tumors via vascular disruption for internal radiation therapy AB Satterlee, JD Rojas, PA Dayton, L Huang Theranostics 7 (2), 253, 2017 | 56 | 2017 |
| A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging AB Satterlee, H Yuan, L Huang Journal of Controlled Release 217, 170-182, 2015 | 47 | 2015 |
| Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection E Graham-Gurysh, KM Moore, AB Satterlee, KT Sheets, FC Lin, ... Molecular pharmaceutics 15 (3), 1309-1318, 2018 | 43 | 2018 |
| Dual functional lipomet mediates envelope-type nanoparticles to combinational oncogene silencing and tumor growth inhibition K Shi, Y Zhao, L Miao, A Satterlee, M Haynes, C Luo, S Musetti, L Huang Molecular Therapy 25 (7), 1567-1579, 2017 | 28 | 2017 |
| Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging R Srinivas, A Satterlee, Y Wang, Y Zhang, Y Wang, L Huang Nanoscale 7 (44), 18542-18551, 2015 | 18 | 2015 |
| Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma AB Satterlee, DE Dunn, DC Lo, S Khagi, S Hingtgen Neuro-oncology 21 (12), 1552-1564, 2019 | 14 | 2019 |
| Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection O Okolie, DM Irvin, JR Bago, K Sheets, A Satterlee, AG Carey-Ewend, ... PloS one 13 (7), e0198596, 2018 | 12 | 2018 |
| Novel murine tumour models depend on strain and route of inoculation Q Fu, A Satterlee, Y Wang, Y Wang, D Wang, J Tang, Z He, F Liu International journal of experimental pathology 97 (4), 351-356, 2016 | 12 | 2016 |
| Quantitative Evaluation of the Mechanism Underlying the Biotransportation of the Active Ingredients in Puerariae lobatae Radix and Chuanxiong rhizoma XL Liang, J Zhang, ZG Liao, GW Zhao, Y Luo, Z Li, A Satterlee Phytotherapy Research 29 (9), 1396-1403, 2015 | 8 | 2015 |
| A living ex vivo platform for functional, personalized brain cancer diagnosis B Mann, X Zhang, N Bell, A Adefolaju, M Thang, R Dasari, K Kanchi, ... Cell Reports Medicine 4 (6), 2023 | 3 | 2023 |
| Spatiotemporal analysis of induced neural stem cell therapy to overcome advanced glioblastoma recurrence AB Satterlee, DE Dunn, A Valdivia, D Malawsky, A Buckley, T Gershon, ... Molecular Therapy-Oncolytics 26, 49-62, 2022 | 3 | 2022 |
| A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study AB Satterlee, P Attayek, B Midkiff, L Huang Radiation Oncology 12, 1-10, 2017 | 3 | 2017 |
| Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma X Cheng, J An, J Lou, Q Gu, W Ding, GN Droby, Y Wang, C Wang, Y Gao, ... Nature Communications 15 (1), 1-20, 2024 | 1 | 2024 |
Leaf HuangProfessor Emeritus, University of North Carolina at Chapel HillVerified email at email.unc.edu
